Darwin Global Management Limited specializes in long-term investments within the biotechnology and pharmaceutical sectors. Founded in Q2 2020 by Abhishek Trehan, it operates as a hedge fund manager with a global investment focus.
Dr. Abhishek Trehan, CEO of Darwin Global, brings extensive experience to the role. Before joining Darwin Global Management, he led biotechnology and pharmaceutical investments at D. E. Shaw & Co. Before his career in finance, Dr. Trehan practiced as a physician. He holds a BA and MA in Pharmacology from the University of Cambridge, a medical degree from the University of Oxford, and an MBA from Harvard Business School.
Darwin Global Management, Ltd., in their latest 13F filing for Q4 2023, disclosed managing $509,483,524 in 13F securities, with a top 10 holdings concentration of 100.0%. Their leading holding is Ambrx Biopharma Inc., with 16,688,636 shares held.
